Point-of-care testing (POCT) has revolutionized healthcare by enabling rapid, on-site diagnostics, with Chinese manufacturers emerging as global innovators. Leveraging advancements in immunochromatography, chemiluminescence, and molecular diagnostics, these companies deliver solutions spanning infectious diseases, chronic conditions, and emergency care, driving accessibility in both clinical and community settings. Here are the top 10 leaders in 2025:
1.Hangzhou Realy Tech Co., Ltd.
Each year we participate in medical shows in various countries such as Medlab, Medica and AACC etc. We have got CE certificates, ISO 13485 quality system certification, Manufacture License, Marketing Authorization in the country of origin. We are also preparing FDA and more other certificates. We are dedicated to making the world a better place by providing people with high quality products and services.
2.Wondfo Biotech
A pioneer with nine technology platforms, including immunofluorescence and molecular diagnostics. Its products cover infectious diseases, chronic illnesses, and drug testing, with 612 global certifications. Exported to 150+ countries, it leads in HIV self-test kits and WHO-prequalified malaria diagnostics.
3.Getein Biotech
Specializes in cardiovascular and infectious disease POCT, integrating with chemiluminescence systems. Its compact devices dominate primary care settings, with reagents for renal injury and inflammation widely adopted in hospitals and clinics nationwide.
4.Mdeasydiagnosis
Offers integrated solutions combining POCT, molecular diagnostics, and telecardiology. Its 10+ technology platforms support emergency care, with smart diagnostic systems linking regional hospitals to enhance critical illness response.
5.Hotgen Biotech
Innovates in liver disease and cancer screening, with UPT and chemiluminescence platforms. Its hepatitis-to-liver cancer diagnostic suite is uniquely comprehensive, while high-throughput systems cater to top-tier hospitals.
6.Orient Gene
Boasts a full 产业链 from antigens to diagnostic chips. Renowned for respiratory pathogen tests, it holds extensive CE/FDA certifications, with rapid antigen kits dominating global markets during public health crises.
7.Sinocare
A leader in diabetes care, offering glucose, lipid, and uric acid monitors. Its iPOCT ecosystem combines electrochemical technology with AI-driven data platforms, capturing 60% of China's home testing market.
8.Alltest Biotech
Excels in drug abuse and infectious disease tests, using colloidal gold and fluorescence technologies. Its women's health and cardiac marker kits are staples in 欧美 clinics, with 50+ products CE-marked.
9.Assure Tech
Focuses on rapid antigen/antibody assays, including malaria and COVID-19 tests. Its chemiluminescence reagents and raw material R&D capabilities support partnerships with 100+ global distributors.
10.Seamaty Technology
Integrates biochemical, 血气,and molecular POCT. With 8 overseas subsidiaries, its veterinary and human diagnostics reach 100+ countries, emphasizing portable, multi-analyte systems.